Latest filing published 18 Jun 2026 for RxSight, Inc.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Jesse Anderson Corley on record concern RxSight, Inc. We count 15 filings; the first trade dates from 30 July 2021 and the latest from 17 June 2026.
The open-market side counts 4 purchases for €1.7M alongside 2 sales for €451k. Netting one side against the other leaves €1.2M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants.
In size, the median ticket on the buying side is €281k. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 18 June 2026 came the latest disclosure, a share grant in RxSight, Inc. The most recent open-market purchase was published on 17 January 2025, 639 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations